Birju Mahavir Arjun ki Chaal - Terminalia Arjuna 400 Gr

Product Information

Traditional medicine system includes the knowledge, skills and practices based on the presumptions, beliefs and experiences of folk communities to protect their health problems. Total 120 patients were screened at OPD of NIUM hospital, Bangalore during 2018-19, only 48 patients fulfilled the inclusion criteria and signed written informed consent and their detailed medical history was recorded. Take empty stomach half spoon of Arjun chaal powder and make kadha in one glass water (in summer or rainy season) or in winter make Kadha with Indian breed desi cow milk or water. M. The treatment of jaundice with medicinal plants in indigenous communities of the Sub-Himalayan region of Uttarakhand, India. It is considered to be tonic, astringent, cooling and is used in heart diseases, contusions, fractures, ulcers.

If someone is not diabetic or hypertensive, then he can take Arjuna for a short period of one month. It fortifies the organ, strengthens heart muscles, prevents accumulation of plaque, prevents hypertension, controls heart rate, etc. Regular use of Arjuna improves the pumping activity of heart, which makes it very useful for heart weakness and congestive heart failure. A significant decrease in serum triglycerides as well as in various inflammatory cytokines such as hsCRP, IL-18 (P < 0. The marked effects on cultured human monocytic and aortic endothelial cells (HAEC) provide the biochemical and molecular basis for the therapeutic potential of T.Medicinal plants contain some organic compounds which provide definite physiological action on the human body and these bioactive substances include tannins, alkaloids, carbohydrates, terpenoids, steroids, flavonoids, and phenols.

TAAE was highly effective in satisfying proinflammatory gene transcripts in THP-1 cells and HAECs, whereas the response to TAWE depended on the type of transcript and cell type. A retrospective study of effect of Terminalia arjuna and evidence based standard therapy on echocardiographic parameters in patients of dilated cardiomyopathy. Arjun Chāl powder (5 gm BD) for eight weeks administered in test group (n=24), Amlodipine (5 mg) and Atorvastatin (10 mg) once a day for same duration administered in control group (n=24). Terminalia arjuna has most often been used by adults in doses of 500 mg by mouth three times daily for up to 3 months.This is due to the presence of various bioactive components such as phenolics, flavonoids, tannins in the bark of Arjuna[10]. Terminalia arjuna enhances baroreflex sensitivity and myocardial function in isoproterenol-induced chronic heart failure in rats. arjuna from Himalayan Herbal Healthcare, Bangalore, India twice a day in addition to receiving the conventional treatment.

arjuna bark extract significantly prevented the isoprenaline-induced increase in oxidative stress and decline in endogenous antioxidant level and also prevented fibrosis. Ethnobotanical studies are most important to expose the ancient times and current culture about plants in the world and reserving original knowledge of medicinal plants.

Even though we are looking towards west, Actually, a mafia has encouraged the allopathic way of treatment for their own benefits and neglected the indian herbs.

arjuna as an anti-ischemic agent and as a potent antioxidant preventing LDL, reperfusion ischemic injury to the heart and its potential to reduce atherogenic lipid levels have been sufficiently demonstrated in different experimental and clinical studies. Because of its astringent and styptic properties, it is also used in pus in urine, UTI and dysentery.

arjuna bark effectively prevented the cerebral I/R induced oxidative damage by virtue of its antioxidant potential and supplementation of arjunolic acid may be beneficial in stroke prone population. arjuna possesses the potent properties of antioxidant and hypolipidemic than other fractions and has therapeutic potential for the prevention of coronary arterial disease. LPS induced tumor necrosis factor (TNF)-α secreted by THP-1 cells and TNF-α induced cell surface adhesion molecules on HAECs, namely vascular cell adhesion molecule-1 (VCAM-1) and E-selectin.